12 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Cellinew

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

Oticon

FDA UDI
Sbo Hearing A/S·05714464055173·OTICON PLAY PX 2 MINIRITE R C093

SYNGO.MR NEUROLOGY, SYNGO.MMR GENERAL

FDA 510(k)
FDA Class 2 ·Radiology

DOVER ROB-NEL CATHETER

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

TERA HARZ CLEAR

FDA Adverse Event
Injury ·GRAPHY INC.·Product code NXC·June 16, 2025

TERA HARZ CLEAR

FDA Adverse Event
Injury ·GRAPHY INC.·Product code NXC·June 16, 2025

TERA HARZ CLEAR

FDA Adverse Event
Injury ·GRAPHY INC.·Product code NXC·June 16, 2025

PRECISION XTRA

FDA Adverse Event
Malfunction ·Product code NBW·September 9, 2011

CURVED CUTTER STAPLER

FDA Adverse Event
Malfunction ·ETHICON ENDO-SURGERY, LLC.·Product code GDW·November 10, 2014

INRATIO2

FDA Adverse Event
Malfunction ·ALERE SAN DIEGO, INC.·Product code GJS·July 17, 2013

Model Number L111, ESSENTIO DR SL MRI Pacemaker

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·October 22, 2025

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014